The Phase 3 trial will be conducted on a large patient population in 12 hospitals all over India. GPP- BALACOVIN is a novel and safe drug that possesses significant efficacy to save the hospitalised patients with oxygen support, from the deadly coronavirus.
PNB Vesper had initiated the phase 2b clinical trial in October 2020 at BJ Government Medical College, Sassoon General Hospital Pune, and Victoria Medical College and Research Institute, Bangalore. The clinical trial protocol was designed in line with the Solidarity Trial conducted by WHO and other international trials.